EMA Wants More Guidance on Import Requirements
Friday, June 5, 2015
Source: FDA News
The European Medicines Agency is calling for additional guidance on good manufacturing and good distribution practices for drug importers.
The guidance is necessary due to the increased complexity of pharma supply chains and increasing numbers of GMP noncompliance statements in the EudraGMDP database regarding third-country manufacturers, according to an EMA concept paper released last week.